Blog
Jack Henry (JKHY) Q3 Earnings Surpass Estimates
Jack Henry (JKHY) came out with quarterly earnings of $1.52 per share, beating the Zacks Consensus Estimate of $1.29 per share. This compares to earnings of $1.19 per share a year ago. These figures
Electronic Arts (EA) Beats Q4 Earnings and Revenue Estimates
Electronic Arts (EA) came out with quarterly earnings of $1.54 per share, beating the Zacks Consensus Estimate of $1.11 per share. This compares to earnings of $1.37 per share a year ago. These
Fortune Brands Innovations (FBIN) Meets Q1 Earnings Estimates
Fortune Brands Innovations (FBIN) came out with quarterly earnings of $0.66 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.83 per share a year ago. These
CRISPR Therapeutics AG (CRSP) Reports Q1 Loss, Misses Revenue Estimates
CRISPR Therapeutics AG (CRSP) came out with a quarterly loss of $1.58 per share versus the Zacks Consensus Estimate of a loss of $1.27. This compares to loss of $1.43 per share a year ago. These
Assurant (AIZ) Beats Q1 Earnings and Revenue Estimates
Assurant (AIZ) came out with quarterly earnings of $3.39 per share, beating the Zacks Consensus Estimate of $2.84 per share. This compares to earnings of $4.78 per share a year ago. These figures
Allegiant Travel (ALGT) Tops Q1 Earnings and Revenue Estimates
Allegiant Travel (ALGT) came out with quarterly earnings of $1.81 per share, beating the Zacks Consensus Estimate of $1.54 per share. This compares to earnings of $0.57 per share a year ago. These
Can Netflix Run Continue Despite Tariff Threat?
The latest tariff news over the weekend had to do with the movie industry. President Trump authorized the Department of Commerce and the USTR to immediately begin the process of instituting 100%
Lyra Therapeutics, Inc. (LYRA) Reports Q1 Loss, Lags Revenue Estimates
Lyra Therapeutics, Inc. (LYRA) came out with a quarterly loss of $0.12 per share versus the Zacks Consensus Estimate of a loss of $0.15. This compares to loss of $0.35 per share a year ago. These
Arista Networks (ANET) Q1 Earnings and Revenues Beat Estimates
Arista Networks (ANET) came out with quarterly earnings of $0.65 per share, beating the Zacks Consensus Estimate of $0.59 per share. This compares to earnings of $0.50 per share a year ago. These
Jazz Pharmaceuticals (JAZZ) Q1 Earnings and Revenues Lag Estimates
Jazz Pharmaceuticals (JAZZ) came out with quarterly earnings of $1.68 per share, missing the Zacks Consensus Estimate of $4.51 per share. This compares to earnings of $2.68 per share a year ago
Super Micro Computer (SMCI) Q3 Earnings and Revenues Top Estimates
Super Micro Computer (SMCI) came out with quarterly earnings of $0.31 per share, beating the Zacks Consensus Estimate of $0.30 per share. This compares to earnings of $0.67 per share a year ago
WW International (WW) Reports Q1 Loss, Lags Revenue Estimates
WW International (WW) came out with a quarterly loss of $0.47 per share versus the Zacks Consensus Estimate of a loss of $0.26. This compares to loss of $0.06 per share a year ago. These figures are
Standard BioTools (LAB) Reports Q1 Loss, Tops Revenue Estimates
Standard BioTools (LAB) came out with a quarterly loss of $0.04 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.23 per share a year ago. These figures are adjusted
Gen Digital (GEN) Q4 Earnings and Revenues Beat Estimates
Gen Digital (GEN) came out with quarterly earnings of $0.59 per share, beating the Zacks Consensus Estimate of $0.58 per share. This compares to earnings of $0.53 per share a year ago. These figures
Revolve Group (RVLV) Q1 Earnings and Revenues Top Estimates
Revolve Group (RVLV) came out with quarterly earnings of $0.16 per share, beating the Zacks Consensus Estimate of $0.13 per share. This compares to earnings of $0.15 per share a year ago. These
Redfin (RDFN) Reports Q1 Loss, Tops Revenue Estimates
Redfin (RDFN) came out with a quarterly loss of $0.73 per share versus the Zacks Consensus Estimate of a loss of $0.69. This compares to loss of $0.57 per share a year ago. These figures are
Dynavax Technologies (DVAX) Reports Q1 Loss, Misses Revenue Estimates
Dynavax Technologies (DVAX) came out with a quarterly loss of $0.11 per share versus the Zacks Consensus Estimate of $0.03. This compares to loss of $0.07 per share a year ago. These figures are
Devon Energy (DVN) Lags Q1 Earnings Estimates
Devon Energy (DVN) came out with quarterly earnings of $1.21 per share, missing the Zacks Consensus Estimate of $1.27 per share. This compares to earnings of $1.16 per share a year ago. These
Wynn Resorts (WYNN) Lags Q1 Earnings and Revenue Estimates
Wynn Resorts (WYNN) came out with quarterly earnings of $1.07 per share, missing the Zacks Consensus Estimate of $1.22 per share. This compares to earnings of $1.59 per share a year ago. These
WideOpenWest (WOW) Reports Q1 Loss, Tops Revenue Estimates
WideOpenWest (WOW) came out with a quarterly loss of $0.17 per share versus the Zacks Consensus Estimate of a loss of $0.19. This compares to loss of $0.18 per share a year ago. These figures are
Ultragenyx (RARE) Reports Q1 Loss, Misses Revenue Estimates
Ultragenyx (RARE) came out with a quarterly loss of $1.57 per share versus the Zacks Consensus Estimate of a loss of $1.54. This compares to loss of $2.03 per share a year ago. These figures are
Cirrus Logic (CRUS) Beats Q4 Earnings and Revenue Estimates
Cirrus Logic (CRUS) came out with quarterly earnings of $1.67 per share, beating the Zacks Consensus Estimate of $1.15 per share. This compares to earnings of $1.24 per share a year ago. These
Voyager Therapeutics (VYGR) Reports Q1 Loss, Lags Revenue Estimates
Voyager Therapeutics (VYGR) came out with a quarterly loss of $0.53 per share versus the Zacks Consensus Estimate of a loss of $0.35. This compares to loss of $0.20 per share a year ago. These
Arcutis Biotherapeutics, Inc. (ARQT) Reports Q1 Loss, Tops Revenue Estimates
Arcutis Biotherapeutics, Inc. (ARQT) came out with a quarterly loss of $0.20 per share versus the Zacks Consensus Estimate of a loss of $0.21. This compares to loss of $0.32 per share a year ago
Cytokinetics (CYTK) Reports Q1 Loss, Lags Revenue Estimates
Cytokinetics (CYTK) came out with a quarterly loss of $1.36 per share versus the Zacks Consensus Estimate of a loss of $1.41. This compares to loss of $1.33 per share a year ago. These figures are


